A systematic review of nicardipine vs labetalol for the management of hypertensive crises

W. Frank Peacock IV, Daniel E. Hilleman, Phillip D. Levy, Denise H. Rhoney, Joseph Varon

Research output: Contribution to journalReview article

29 Citations (Scopus)

Abstract

Hypertensive emergencies are acute elevations in blood pressure (BP) that occur in the presence of progressive end-organ damage. Hypertensive urgencies, defined as elevated BP without acute end-organ damage, can often be treated with oral agents, whereas hypertensive emergencies are best treated with intravenous titratable agents. However, a lack of head-to-head studies has made it difficult to establish which intravenous drug is most effective in treating hypertensive crises. This systematic review presents a synthesis of published studies that compare the antihypertensive agents nicardipine and labetalol in patients experiencing acute hypertensive crises. A MEDLINE search was conducted using the term labetalol AND nicardipine AND hypertension. Conference abstracts were searched manually. Ultimately, 10 studies were included, encompassing patients with hypertensive crises across an array of indications and practice environments (stroke, the emergency department, critical care, surgery, pediatrics, and pregnancy). The results of this systematic review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol.

Original languageEnglish
Pages (from-to)981-993
Number of pages13
JournalAmerican Journal of Emergency Medicine
Volume30
Issue number6
DOIs
StatePublished - Jul 2012

Fingerprint

Labetalol
Nicardipine
Blood Pressure
Emergencies
Critical Care
MEDLINE
Antihypertensive Agents
Hospital Emergency Service
Stroke
Pediatrics
Hypertension
Safety
Pregnancy
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Emergency Medicine

Cite this

A systematic review of nicardipine vs labetalol for the management of hypertensive crises. / Peacock IV, W. Frank; Hilleman, Daniel E.; Levy, Phillip D.; Rhoney, Denise H.; Varon, Joseph.

In: American Journal of Emergency Medicine, Vol. 30, No. 6, 07.2012, p. 981-993.

Research output: Contribution to journalReview article

Peacock IV, W. Frank ; Hilleman, Daniel E. ; Levy, Phillip D. ; Rhoney, Denise H. ; Varon, Joseph. / A systematic review of nicardipine vs labetalol for the management of hypertensive crises. In: American Journal of Emergency Medicine. 2012 ; Vol. 30, No. 6. pp. 981-993.
@article{004de3adc6954da6b981554073b47469,
title = "A systematic review of nicardipine vs labetalol for the management of hypertensive crises",
abstract = "Hypertensive emergencies are acute elevations in blood pressure (BP) that occur in the presence of progressive end-organ damage. Hypertensive urgencies, defined as elevated BP without acute end-organ damage, can often be treated with oral agents, whereas hypertensive emergencies are best treated with intravenous titratable agents. However, a lack of head-to-head studies has made it difficult to establish which intravenous drug is most effective in treating hypertensive crises. This systematic review presents a synthesis of published studies that compare the antihypertensive agents nicardipine and labetalol in patients experiencing acute hypertensive crises. A MEDLINE search was conducted using the term labetalol AND nicardipine AND hypertension. Conference abstracts were searched manually. Ultimately, 10 studies were included, encompassing patients with hypertensive crises across an array of indications and practice environments (stroke, the emergency department, critical care, surgery, pediatrics, and pregnancy). The results of this systematic review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol.",
author = "{Peacock IV}, {W. Frank} and Hilleman, {Daniel E.} and Levy, {Phillip D.} and Rhoney, {Denise H.} and Joseph Varon",
year = "2012",
month = "7",
doi = "10.1016/j.ajem.2011.06.040",
language = "English",
volume = "30",
pages = "981--993",
journal = "American Journal of Emergency Medicine",
issn = "0735-6757",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - A systematic review of nicardipine vs labetalol for the management of hypertensive crises

AU - Peacock IV, W. Frank

AU - Hilleman, Daniel E.

AU - Levy, Phillip D.

AU - Rhoney, Denise H.

AU - Varon, Joseph

PY - 2012/7

Y1 - 2012/7

N2 - Hypertensive emergencies are acute elevations in blood pressure (BP) that occur in the presence of progressive end-organ damage. Hypertensive urgencies, defined as elevated BP without acute end-organ damage, can often be treated with oral agents, whereas hypertensive emergencies are best treated with intravenous titratable agents. However, a lack of head-to-head studies has made it difficult to establish which intravenous drug is most effective in treating hypertensive crises. This systematic review presents a synthesis of published studies that compare the antihypertensive agents nicardipine and labetalol in patients experiencing acute hypertensive crises. A MEDLINE search was conducted using the term labetalol AND nicardipine AND hypertension. Conference abstracts were searched manually. Ultimately, 10 studies were included, encompassing patients with hypertensive crises across an array of indications and practice environments (stroke, the emergency department, critical care, surgery, pediatrics, and pregnancy). The results of this systematic review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol.

AB - Hypertensive emergencies are acute elevations in blood pressure (BP) that occur in the presence of progressive end-organ damage. Hypertensive urgencies, defined as elevated BP without acute end-organ damage, can often be treated with oral agents, whereas hypertensive emergencies are best treated with intravenous titratable agents. However, a lack of head-to-head studies has made it difficult to establish which intravenous drug is most effective in treating hypertensive crises. This systematic review presents a synthesis of published studies that compare the antihypertensive agents nicardipine and labetalol in patients experiencing acute hypertensive crises. A MEDLINE search was conducted using the term labetalol AND nicardipine AND hypertension. Conference abstracts were searched manually. Ultimately, 10 studies were included, encompassing patients with hypertensive crises across an array of indications and practice environments (stroke, the emergency department, critical care, surgery, pediatrics, and pregnancy). The results of this systematic review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol.

UR - http://www.scopus.com/inward/record.url?scp=84863194773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863194773&partnerID=8YFLogxK

U2 - 10.1016/j.ajem.2011.06.040

DO - 10.1016/j.ajem.2011.06.040

M3 - Review article

VL - 30

SP - 981

EP - 993

JO - American Journal of Emergency Medicine

JF - American Journal of Emergency Medicine

SN - 0735-6757

IS - 6

ER -